ATE228164T1 - Chemotaktische faktoren - Google Patents

Chemotaktische faktoren

Info

Publication number
ATE228164T1
ATE228164T1 AT91916523T AT91916523T ATE228164T1 AT E228164 T1 ATE228164 T1 AT E228164T1 AT 91916523 T AT91916523 T AT 91916523T AT 91916523 T AT91916523 T AT 91916523T AT E228164 T1 ATE228164 T1 AT E228164T1
Authority
AT
Austria
Prior art keywords
pct
sec
date
chemotactic
date apr
Prior art date
Application number
AT91916523T
Other languages
English (en)
Inventor
Carolyn Geczy
Richard John Simpson
Martin Lackmann
Original Assignee
Heart Res Inst Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heart Res Inst Ltd filed Critical Heart Res Inst Ltd
Application granted granted Critical
Publication of ATE228164T1 publication Critical patent/ATE228164T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Sorption Type Refrigeration Machines (AREA)
  • Input Circuits Of Receivers And Coupling Of Receivers And Audio Equipment (AREA)
AT91916523T 1990-09-05 1991-09-05 Chemotaktische faktoren ATE228164T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPK212790 1990-09-05
AUPK446391 1991-02-05
PCT/AU1991/000410 WO1992004376A1 (en) 1990-09-05 1991-09-05 Novel chemotactic factor

Publications (1)

Publication Number Publication Date
ATE228164T1 true ATE228164T1 (de) 2002-12-15

Family

ID=25643937

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91916523T ATE228164T1 (de) 1990-09-05 1991-09-05 Chemotaktische faktoren

Country Status (6)

Country Link
US (1) US5731166A (de)
EP (1) EP0550506B1 (de)
AT (1) ATE228164T1 (de)
DE (1) DE69133159D1 (de)
SG (1) SG66214A1 (de)
WO (1) WO1992004376A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6713605B1 (en) * 1996-04-10 2004-03-30 Kansas State University Research Foundation Synthetic peptides that inhibit leukocyte superoxide anion production and/or attract leukocytes
AU6030398A (en) 1997-01-21 1998-08-07 Auckland Uniservices Limited Human proteins
ATE405647T1 (de) 1999-11-12 2008-09-15 Fibrogen Inc Rekombinantes gelatin in impstoffen
EP1114862A3 (de) * 1999-11-17 2003-08-06 Switch Biotech Aktiengesellschaft Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankungen sowie ihre Verwendung zur Identifizierung von pharmakologisch aktiven Substanzen
US6908899B2 (en) * 2001-08-17 2005-06-21 U.S. Dept. Of Veterans Affairs Pro-inflammatory fibrinopeptide
AU2003236762A1 (en) * 2002-07-05 2004-01-23 Universite Laval Chemotactic factor inhibitor for modulating inflammatory reactions
WO2004084928A1 (en) 2003-03-28 2004-10-07 UNIVERSITé LAVAL S100 protein as neutrophil activator for alleviating neutropenia in cancer treatment
WO2004089292A2 (en) * 2003-04-04 2004-10-21 The Regents Of The University Of California Immunomodulatory agents for treatment of inflammatory diseases
US7449116B2 (en) * 2004-10-01 2008-11-11 Agilent Technologies, Inc. Methods and systems for protein separation
US7943046B2 (en) * 2004-10-01 2011-05-17 Agilent Technologies, Inc Methods and systems for on-column protein delipidation
US8173598B2 (en) * 2008-08-29 2012-05-08 The Board Of Trustees Of The University Of Illinois Myeloid protein activation of anti-inflammatory and anti-hypoxic pathway

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2052602T3 (es) * 1986-10-03 1994-07-16 Ciba Geigy Ag Nuevos peptidos afines a las linfocinas.
IL92938A (en) * 1989-01-01 1998-08-16 Us Commerce A polypeptide that has a mutagenic activity on monocytes and AND that encodes it

Also Published As

Publication number Publication date
US5731166A (en) 1998-03-24
EP0550506A1 (de) 1993-07-14
SG66214A1 (en) 1999-07-20
WO1992004376A1 (en) 1992-03-19
EP0550506B1 (de) 2002-11-20
EP0550506A4 (en) 1994-06-08
DE69133159D1 (de) 2003-01-02

Similar Documents

Publication Publication Date Title
ATE228164T1 (de) Chemotaktische faktoren
ATE170192T1 (de) Zusammensetzungen und methoden zur synthese des b-rezeptors für das natriuretische protein und verwendungsmethoden
DE59610632D1 (de) Varianten des humanen rekombinanten interferon-gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität
DE69334350D1 (de) P- Selectin Ligandenprotein
DK0754229T3 (da) Afamin: et humant serum albumin-lignende protein
ATE121754T1 (de) Vakzine gegen bordetella.
DE68917837T2 (de) Peptid-Verbindungen.
DK0567503T3 (da) Gen for Pasteurella haemolytica glycoprotease, samt det rensede enzym.
SE8902507L (sv) Neutrofil-aktiverande faktor
DK0594771T3 (da) Cycloheximidresistens i nukleotidsekvenser og -proteiner
DE59712235D1 (de) Immunologisch aktive proteine von borrelia burgdorferi, dafür kodierende nukleinsäuren sowie deren verwendung in testkits und als impfstoffe
DK0687270T3 (da) Osteogene vækstoligopeptider og farmaceutiske præparater indeholdende disse
EP0310887A3 (en) Vasoconstrictor peptide
ATE233321T1 (de) Verbesserungen in der herstellung von proteinen in wirtszellen
ES2052482T3 (es) Inhibidor de la proliferacion de celulas endoteliales.
ATE454450T1 (de) Proteine, das auf hämatopoietischen stammzellen der lymphoid und nk linien zu finden ist, und verwendungen davon
DK0610246T3 (da) Hidtil ukendt thrombininhiberende protein fra blodmider
EP1295943A4 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
于秉治 et al. Purification of Protein Kinase C Inhibitor from Bovine Spermatozoa
MY103637A (en) Neutrophil-activating factor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties